← Pharmacist Notes

DRUG · COUNSELLING NOTES

Natalizumab

Tysabri

Updated

New prescription

indication: _____. IV in clinic; report new weakness or vision/memory changes; carry alert card; warned on allergies; serious/common AEs: PML, infusion reaction, headache; non-pharm: pacing, exercise

Refill prescription

refilled, adherence discussed, no SEs were reported

Dose change

Dose change discussed. new dose reviewed; IV in clinic; report new weakness or vision/memory changes; carry alert card; warned on allergies; serious/common AEs: PML, infusion reaction, headache; non-pharm: pacing, exercise

View Natalizumab in the Drug Database

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.